The Medicines Company announced that its Board of Directors has named Dr. Fred Eshelman, founder of Eshelman Ventures LLC, as non-executive Chairman of the company's Board of Directors, effective immediately. Dr. Clive Meanwell will remain the company's Chief Executive Officer and a member of the Board of Directors. Dr. Eshelman has more than 35 years of strategic development, executive, operational and financial leadership experience in the pharmaceutical and healthcare industries.

He is the founder and former Chief Executive Officer and Executive Chairman of Pharmaceutical Product Development Inc. (PPD). Dr. Eshelman will serve as a Class II director with a term expiring at the 2017 Annual Meeting of Shareholders.